本研究為一項前瞻性隊列研究，旨在描述在無抗生素預防下進行經會陰前列腺穿刺活檢後的感染結果及發生率，並與現有接受抗生素預防下經會陰前列腺穿刺活檢患者的結果數據進行比較。
適應症：Prostate Cancer
收案條件
納入條件
- All consecutive patients in participating centres receiving transperineal USG-guided biopsy for any indication including:
- Elevated PSA
- Abnormal DRE
- Follow-up biopsy in active surveillance
- Suspicion of CAP recurrence after radiotherapy
- Follow-up biopsy after focal therapy
- Consenting to the study
排除條件
- Recent suspected UTI within 1 month
- Recent culture proven bacteriuria within 1 month
- History of recurrent UTI
- Indwelling urinary catheter
- Immunocompromised state
- High risk of infective endocarditis (including prosthetic heart valve, congenital heart disease, or previous history of infective endocarditis
- Incompetent or incapable of understanding the nature of the study or giving informed consent
收案條件維持 ClinicalTrials.gov 原始英文登錄資料，實際收案資格以研究團隊的正式評估與受試者同意書為準。資料來源：ClinicalTrials.gov，每兩週自動更新，最後同步：2026年10月8日。